• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与钙化性主动脉瓣疾病相关的临床因素。心血管健康研究。

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

作者信息

Stewart B F, Siscovick D, Lind B K, Gardin J M, Gottdiener J S, Smith V E, Kitzman D W, Otto C M

机构信息

Department of Medicine, University of Washington, Seattle 98195-6422, USA.

出版信息

J Am Coll Cardiol. 1997 Mar 1;29(3):630-4. doi: 10.1016/s0735-1097(96)00563-3.

DOI:10.1016/s0735-1097(96)00563-3
PMID:9060903
Abstract

OBJECTIVES

The aim of this study was to determine the prevalence of aortic sclerosis and stenosis in the elderly and to identify clinical factors associated with degenerative aortic valve disease.

BACKGROUND

Several lines of evidence suggest that degenerative aortic valve disease is not an inevitable consequence of aging and may be associated with specific clinical factors.

METHODS

In 5,201 subjects > or = 65 years of age enrolled in the Cardiovascular Health Study, the relation between aortic sclerosis or stenosis identified on echocardiography and clinical risk factors for atherosclerosis was evaluated by using stepwise logistic regression analysis.

RESULTS

Aortic valve sclerosis was present in 26% and aortic valve stenosis in 2% of the entire study cohort; in subjects > or = 75 years of age, sclerosis was present in 37% and stenosis in 2.6%. Independent clinical factors associated with degenerative aortic valve disease included age (twofold increased risk for each 10-year increase in age), male gender (twofold excess risk), present smoking (35% increase in risk) and a history of hypertension (20% increase in risk). Other significant factors included height and high lipoprotein(a) and low density lipoprotein cholesterol levels.

CONCLUSIONS

Clinical factors associated with aortic sclerosis and stenosis can be identified and are similar to risk factors for atherosclerosis.

摘要

目的

本研究旨在确定老年人主动脉硬化和狭窄的患病率,并确定与退行性主动脉瓣疾病相关的临床因素。

背景

多项证据表明,退行性主动脉瓣疾病并非衰老的必然结果,可能与特定临床因素有关。

方法

在心血管健康研究中纳入的5201名年龄≥65岁的受试者中,通过逐步逻辑回归分析评估超声心动图检查发现的主动脉硬化或狭窄与动脉粥样硬化临床危险因素之间的关系。

结果

在整个研究队列中,主动脉瓣硬化的发生率为26%,主动脉瓣狭窄的发生率为2%;在年龄≥75岁的受试者中,硬化的发生率为37%,狭窄的发生率为2.6%。与退行性主动脉瓣疾病相关的独立临床因素包括年龄(每增加10岁风险增加一倍)、男性(风险高出两倍)、当前吸烟(风险增加35%)和高血压病史(风险增加20%)。其他重要因素包括身高、高脂蛋白(a)和低密度脂蛋白胆固醇水平。

结论

与主动脉硬化和狭窄相关的临床因素可以被识别,且与动脉粥样硬化的危险因素相似。

相似文献

1
Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.与钙化性主动脉瓣疾病相关的临床因素。心血管健康研究。
J Am Coll Cardiol. 1997 Mar 1;29(3):630-4. doi: 10.1016/s0735-1097(96)00563-3.
2
Determinants of occurrence of aortic sclerosis in an aging population.老年人群主动脉硬化发生的决定因素。
JACC Cardiovasc Imaging. 2009 Aug;2(8):919-27. doi: 10.1016/j.jcmg.2009.03.016.
3
Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area.老年钙化性主动脉瓣疾病的流行情况及相关危险因素:地中海地区的一项基于人群的研究。
Eur J Prev Cardiol. 2013 Dec;20(6):1022-30. doi: 10.1177/2047487312451238. Epub 2012 Jun 7.
4
Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.临床因素而非C反应蛋白可预测钙化性主动脉瓣疾病的进展:心血管健康研究
J Am Coll Cardiol. 2007 Nov 13;50(20):1992-8. doi: 10.1016/j.jacc.2007.07.064. Epub 2007 Oct 29.
5
Aortic valve sclerosis as a marker of active atherosclerosis.主动脉瓣硬化作为活动性动脉粥样硬化的一个标志物。
Curr Cardiol Rep. 2002 Mar;4(2):111-7. doi: 10.1007/s11886-002-0022-8.
6
Osseous and chondromatous metaplasia in calcific aortic valve stenosis.钙化性主动脉瓣狭窄中的骨化生和软骨化生
Cardiovasc Pathol. 2016 Jan-Feb;25(1):18-24. doi: 10.1016/j.carpath.2015.08.008. Epub 2015 Aug 29.
7
Aortic sclerosis--a marker of coronary atherosclerosis.主动脉硬化——冠状动脉粥样硬化的一个标志物。
Clin Cardiol. 2004 Dec;27(12):671-3. doi: 10.1002/clc.4960271202.
8
Risk factor profile of calcific aortic stenosis.钙化性主动脉瓣狭窄的风险因素谱
Indian Heart J. 2016 Nov-Dec;68(6):828-831. doi: 10.1016/j.ihj.2016.04.007. Epub 2016 Apr 28.
9
Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.老年人群中主动脉瓣硬化与心血管疾病死亡率和发病率的关联。
N Engl J Med. 1999 Jul 15;341(3):142-7. doi: 10.1056/NEJM199907153410302.
10
Ideal Cardiovascular Health and the Prevalence and Severity of Aortic Stenosis in Elderly Patients.理想心血管健康与老年患者主动脉瓣狭窄的患病率和严重程度。
J Am Heart Assoc. 2018 Feb 3;7(3):e007234. doi: 10.1161/JAHA.117.007234.

引用本文的文献

1
TAVI plus PCI versus SAVR plus CABG: Long-term outcome of a multicentre-registry.经导管主动脉瓣植入术联合经皮冠状动脉介入治疗与外科主动脉瓣置换术联合冠状动脉旁路移植术:一项多中心注册研究的长期结果
Clin Res Cardiol. 2025 Sep 11. doi: 10.1007/s00392-025-02755-9.
2
Clinical Outcomes of Surgical Revascularization in Patients Presenting with Critical Limb Ischemia and Aortic Valve Stenosis.严重肢体缺血合并主动脉瓣狭窄患者外科血运重建的临床结局
J Cardiovasc Dev Dis. 2025 Jul 31;12(8):292. doi: 10.3390/jcdd12080292.
3
Comparison of different timings of percutaneous coronary intervention in patients with transcatheter aortic valve implantation: a network meta-analysis.
经导管主动脉瓣植入患者经皮冠状动脉介入治疗不同时机的比较:一项网状Meta分析。
Front Cardiovasc Med. 2025 Aug 1;12:1596208. doi: 10.3389/fcvm.2025.1596208. eCollection 2025.
4
Optimizing transcatheter aortic valve implantation work-up: the role of preprocedural computed tomography for the screening of concomitant coronary artery disease.优化经导管主动脉瓣植入术前评估:术前计算机断层扫描在筛查合并冠状动脉疾病中的作用。
J Thorac Dis. 2025 Jul 31;17(7):4392-4394. doi: 10.21037/jtd-24-182. Epub 2025 Jul 29.
5
Unveiling the intricacies of cardiac valve pathophysiology.揭示心脏瓣膜病理生理学的复杂性。
Front Cardiovasc Med. 2025 Jul 24;12:1570271. doi: 10.3389/fcvm.2025.1570271. eCollection 2025.
6
Understanding Aortic Stenosis and Transcatheter Aortic Valve Replacement in Women.了解女性主动脉瓣狭窄及经导管主动脉瓣置换术
Struct Heart. 2025 May 30;9(7):100666. doi: 10.1016/j.shj.2025.100666. eCollection 2025 Jul.
7
The Association of Aortic Stenosis Severity and Symptom Status With Morbidity and Mortality.主动脉瓣狭窄严重程度及症状状态与发病率和死亡率的关联
JACC Adv. 2025 Jul 21;4(8):101962. doi: 10.1016/j.jacadv.2025.101962.
8
Novel model of cardiac hypertrophy with cardiorenal dysfunction.伴有心肾功能障碍的新型心脏肥大模型。
Sci Rep. 2025 Jul 19;15(1):26242. doi: 10.1038/s41598-025-90435-z.
9
Temporal trends in TAVI outcomes: experience from an Irish tertiary referral centre.经导管主动脉瓣植入术(TAVI)治疗结果的时间趋势:来自爱尔兰一家三级转诊中心的经验
Ir J Med Sci. 2025 Jul 10. doi: 10.1007/s11845-025-04001-7.
10
Management of conduction disturbances after TAVI: the last step towards early discharge.经导管主动脉瓣植入术后传导障碍的管理:迈向早期出院的最后一步。
J Geriatr Cardiol. 2025 May 28;22(5):534-546. doi: 10.26599/1671-5411.2025.05.004.